Role of cytokines in the response to erythropoietin in hemodialysis patients

Kidney International

Volumn 54, Issue 4, 1998, Pages 1337-1343

  Goicoechea, Marian ^a   Martin, Julio ^a   De Sequera, Patricia ^a   Quiroga, Juan A ^a   Ortiz, Alberto ^a   Carreño, Vicente ^a   Caramelo, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cytokines; Erythropoietin responsiveness; Hemodialysis; Interferon ; Interleukins; Tumor necrosis factor

Indexed keywords

ALUMINUM; ERYTHROPOIETIN; FERRITIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG INDICATION; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031682119     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00084.x     Document Type: Article

References (35)

1. VALDERRÁBANO F: Erythropoietin in chronic renal failure. Kidney Int 50:1373-1391, 1996
2. STIVELMAN JC: Resistance to recombinant human erythropoietin therapy: A real clinical entity? Semin Nephrol 9(Suppl 2):8-11, 1989
3. DRÜEKE TB: R-HuEPO hyporesponsiveness-Who and why? Nephrol Dial Transplant 10(Suppl 2):62-68, 1995
4. DANIELSON B: R-HuEPO hyporesponsiveness-Who and why? Nephrol Dial Transplant 10(Suppl 2):69-73, 1995
5. VAN WYCK DB, STIVELMAN JC, RUIZ J, KIRVIN LF, KATZ MA, ODGEN DA: Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int 35:712-716, 1989
6. RAO DS, SHIH MS, MOHINI R: Effect of serum parathyroid hormone on bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328:171-175, 1993
7. CANNATA JB, FERNÁNDEZ-SOTO Y, FERNÁNDEZ-MENENDEZ MJ, FERNÁNDEZ-MARTÍN JL, MCGREGOR SJ, BROCK JH, HALLS D: Role of iron metabolism in absorption and cellular uptake of aluminum. Kidney Int 39:799-803, 1991
8. ZOUMBOS N, RAEFSKY E, YOUNG N: Lymphokines and hematopoiesis. Progr Hematol 14:201-234, 1986
9. BALKWILL FR, BURKE F: The cytokine network. Immunol Today 10:299-304, 1989
10. DINARELLO CA, MIER JW: Current concepts in lymphokines. N Engl J Med 317:940-945, 1987
11. ZANJANI DE, MCGLOVE PB, DAVIES SF, BANISADRE M, KOPLAN ME, SAROSI GA: In vitro supression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. Br J Hematol 50:479-490, 1982
12. DESCAMPS-LATSCHA B, HERBELIN A: Long-term dialysis and cellular immunity: A critical survey. Kidney Int 43(Suppl 41):S135-S142, 1993
13. HERBELIN A, UREÑA P, NGUYEN AT, ZINGRAFF J, DESCAMPS-LATSCHA B: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 39:954-960, 1991
14. HERBELIN A, NGUYEN AT, ZINGRAFF J, UREÑA P, DESCAMPS-LATSCHA B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor a. Kidney Int 37:116-125, 1990
15. DESCAMPS-LATSCHA B, HERBELIN A, NGUYEN AT, MOUX-LOMBARD P, ZINGRAFF J, MOYNOT A, VERGER C, DAHMANE D, DE GROOTE D, JUNGERS P, DAYER JM: Balance between IL-1β, TNFα and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 154:882-892, 1995
16. MACDONALD C, RUSH DN, BERNSTEIN KN, MCKENNA RM: Production of tumor necrosis factor alpha and hemodialysis. Nephron 65:273-277, 1993
17. MACDOUGALL IC: Poor response to erythropoietin: Practical guidelines on investigation and management. Nephrol Dial Transplant 10:607-614, 1995
18. DYBEDAD Y, LARSEN S, JACOBSEN SEW: IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor. J Immunol 154:4950-4955, 1995
19. BELLONE G, TRINCHIERI G: Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hemopoiesis. J Inmunol 153:930-937, 1994
20. DE SEQUERA P, MARTIN J, QUIROGA JA, NAVAS S, CARREÑO V, CARAMELO C: Cytokine production in hemodialyzed patients infected with hepatitis C virus (HCV). (abstract) J Am Soc Nephrol 8:233, 1997
21. QUIROGA JA, MARTIN J, NAVAS S, CARREÑO V: Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage. J Infect Dis (in press)
22. CARAMELO C, CANNATA JB, RODELES MR, FERNÁNDEZ-MARTÍN JL, MOSQUERA JR, MONZU B, BLUM G, ANDREA C, LÓPEZ-FARRÉ AJ, ACUÑA G, CASADO S, HERNANDO L: Mechanisms of aluminum-induced microcytosis: Lessons from accidental aluminum intoxication. Kidney Int 54:164-168, 1995
23. MILLER CB, JONES RJ, PRANDATOSI S, AVELOFF MG, SPIVAK JL: Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689-1692, 1990
24. BROXMEYER HE, LU L, PLATZER E, FEIT C, JULIANO L, RUBIN BY: Comparative analysis of the influences of human γ, α and β interferons on human multipotential (CFU-GEMM) erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Inmunol 131: 1300-1305, 1983
25. LU L, WELTE K, GABRILOVE JL, HANGOC G, BRUNO E, HOFFMAN R, BROXMEYER HE: Effects of recombinant human tumor necrosis factor α, recombinant human γ-interferon and prostaglandin E and colony forming human hematopoietic progenitor cells stimulated by natural human pluripotent colony stimulating factor pluripoietin α and recombinant erythropoietin in serum-free cultures. Cancer Res 46:4357-4361, 1986
26. SCHOOLEY JC, KULLGREN B, ALLISON AC: Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. Br J Haematol 67:11-17, 1987
27. MACDOUGALL IC, ALLEN DA, CAVILL I, BAKER LRI, RAINE AEG: Poor response to erythropoietin in inflammatory conditions may be mediated by interleukin-6. (abstract) Nephrol Dial Transplant 9:1033, 1994
28. WOLF SF, SIEBURTH D, SYPEK J: Interleukin 12: A key modulator of immune function. Stem Cells Dayt 12:154-168, 1994
29. GATELY MK, WARRIER RR, HONASOGE S, CARVAJAL DM, FAHERTY DD, CONNAUGHTON SE, ANDERSON TD, SARMIENTO U, HUBBARD BR, MURPHY M: Administration of recombinant IL12 to normal mice enhances cytolytic lymphocyte activity and induces production of TFNγ in vivo. Int Immunol 6:157-167, 1994
30. CHAN SH, PERUSSIA B, GUPTA JW, KOBAYASHI M, POSPISIL M, YOUNG HA, WOLF SF, YOUNG A, CLARK SC, TRINCHIERI G: Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J Exp Med 173:869-879, 1991
31. GATELY MK, DESAI BB, WOLITZKY AG, QUINN PM, DWYER CM, PODLASKI FJ, FOMILLETI PC, SINIGAGLIA F, CHIZONNITE R, GUBBLER U, STERN AS: Regulation of human lymphocyte profileration by a heterodimeric cytokine Il-12 (cytotoxic lymphocyte maturation factor). (abstract) J Immunol 147:874, 1991
32. JOHNSON RA, COOK CA, FURMANSKI P: In vivo supression of erythropoiesis by tumor necrosis factor alpha (TNF-α): Reversal with exogenous erythropoietin. Exp Hematol 18:109-115, 1990
33. ROSENLÖF K, KIVIVUORI SM, GRÖNHAGEN-RISKA C, TEPPO AM, SLIMES MA: Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrol 443:249-255, 1995
34. BARANY P, DIVINO FILHO JC, BERGSTROM J: High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29:565-568, 1997
35. VAZIRI ND, WANF J, CESARIO T, YOUSEGI S, VALENZUELA R, CARANDANG G: Induction, transcription, synthesis and adsorption of interleukin-1 by dialyzer membranes. J Am Soc Nephrol 4:1884-1889, 1994